Synopsis of recent research by authors named "Zhiliang Hu"
- Zhiliang Hu's research concentrates on clinical and microbiological advancements, particularly addressing severe infections such as SFTS and drug-resistant tuberculosis, utilizing innovative methodologies like risk scoring models and advanced sequencing techniques.
- Recent studies have focused on evaluating the effectiveness of various treatments for infections caused by ESKAPEE pathogens, HIV-associated central nervous system infections, and the application of inactivated COVID-19 vaccines in mitigating severe illness.
- Hu's work also delves into the molecular mechanisms in aggressive cancers, notably intrahepatic cholangiocarcinoma, using insights into stemness and chemoresistance to inform therapeutic approaches and improve patient outcomes.
